Lichen Extract Formulation for Prion Breakdown

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Chronic wasting disease (CWD) transmission among cervids is exacerbated by animal congregation and environmental contamination, with existing methods failing to effectively address the spread of infectious prions.

Innovation Solution

A formulation combining reindeer lichen extract (Cladonia rangiferina), lung lichen extract (Lobaria pulmonaria), and witch's hair lichen extract (Alectoria sarmentosa) is developed for use in feed pellets, protein blocks, drinking water, and spray cleaners to potentially break down infectious prions, with varying extract ratios and additives for stability and digestibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If lichen extracts are added to feed formulations to break down prions, then CWD transmission is reduced, but formulation stability and digestibility must be maintained

Engineering Contradiction:
ImproveCWD transmission reductionVSAvoidformulation stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent combines multiple lichen extracts (Cladonia rangiferina, Lobaria pulmonaria, Alectoria sarmentosa) with specific ratios (1:1:1 to 40:1:5 by weight) to create a composite formulation that maintains stability while achieving prion breakdown. This composite approach allows the synergistic effects of different lichen compounds to work together, resolving the contradiction between disease reduction and formulation stability.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent optimizes the concentration parameters of lichen extracts in the formulation, using ranges from 1% to 40% by weight for each extract type. By adjusting these parameters, the formulation achieves effective prion degradation while maintaining acceptable stability and digestibility characteristics.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If high concentrations of lichen extracts are used to maximize prion breakdown, then CWD transmission is more effectively reduced, but digestibility and animal health may be compromised

Engineering Contradiction:
Improveprion breakdown efficiencyVSAvoiddigestibility and animal health
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent establishes optimal concentration ranges for lichen extracts (1-40% by weight for Cladonia and Lobaria, 5-45% for Alectoria) that balance prion breakdown efficiency with animal health and digestibility. This parameter optimization prevents excessive concentrations that could harm animal health while maintaining effective disease reduction.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The use of a composite lichen extract mixture with specific ratios (1:1:1 to 40:1:5) creates a balanced formulation where the combined effects of different lichen species achieve prion degradation without the harmful effects of high concentrations of single extracts, thereby maintaining digestibility and animal health.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The lichen extract-based formulations demonstrate enhanced digestibility and stability, effectively reducing CWD transmission by utilizing the antibiotic and antiviral properties of these lichen extracts, thereby mitigating environmental contamination and animal infection.

Implementation Method 1

Lichens produce unique organic compounds that have antibiotic and antiviral properties

Methodology Applied
Scientific EffectAntibiotic and antiviral properties:

Data Source

PatentUS20240091289A1Lichen Extract-based Formulation for Cervids
Publication Date: 2024.03.21 ZOO PHARMA DYNAMICS LLC
  • US20240091289A1 patent drawing
  • US20240091289A1 patent drawing
  • US20240091289A1 patent drawing

AI summary

A lichen extract-based formulation containing a mixture of reindeer lichen extract (Cladonia rangiferina), lung lichen extract (Lobaria pulmonaria), and witch's hair lichen extract (Alectoria sarmentosa); feed pellet, protein block and solution containing the lichen extract-based formulation; lichen extract-based spray cleaner formulation and methods for administration of the formulations to cervids are disclosed.